HMOX1 and Miyoshi myopathy: Through the study of cytotherapy with mesenchymal stem cells (MSCs) for treating MM, we discovered that MSCs mediate HMOX1 expression in monocytes to balance differentiation of osteoclast precursors into osteoclasts.